65
X4 Pharmaceuticals, Inc raises $85M under Reg D
Company raise · Closed · BOSTON, MA · Form D filed 2025-08-25
$50M+ raiseFirst raise on EDGARPlacement agent engaged
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| Mary DiBiase | Executive Officer |
| Murray W. Stewart | Director |
| Christophe Arbet-Engels | Executive Officer |
| David Kirske | Executive Officer |
| Michael S. Wyzga | Director |
| John Volpone | Executive Officer |
| Mark Baldry | Executive Officer |
| Francoise J. De Craecker | Director |
| Gary J. Bridger | Director |
| Adam Craig | Executive Officer, Director |
Signed by Natasha Thoren, Chief Legal Officer.
Placement agents / sales compensation: STIFEL, NICOLAUS & COMPANY, INCORPORATED
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.